Streamline Prostate Cancer Screenings with Prostate.Carcinoma.ai in mint Lesion
The Prostate.Carcinoma.ai plug-in, developed by our partner FUSE-AI, is a powerful addition to mint Lesion, designed specifically to enhance prostate…
LMU Munich: Prospective study shows the suitability of a semi-automatic approach to assess changes in prostate MRI after prostatic artery embolization
A prospective, monocentric study [1] conducted by Vanessa F. Schmidt and her colleagues at the University Hospital Munich (LMU) evaluated the…
mint PI-RADS V2 report as the standard for communication with urologists - Interview with PD Dr. Röthke
Since the beginning of 2017, all PI-RADS v2 reads are exclusively performed with mint Lesion™ by PD Dr. Matthias Röthke, Chief Medical Officer at…
About Cookies
This website uses cookies. Those have two functions: On the one hand they are providing basic functionality for this website. On the other hand they allow us to improve our content for you by saving and analyzing anonymized user data. You can redraw your consent to using these cookies at any time. Find more information regarding cookies on our Data Protection Declaration and regarding us on the Imprint.
